There is a close relationship between a person's mental health and gastrointestinal disorders. Psychogenic dysphagia is a rare condition related to swallowing disorders with no structural cause or organic diseases such as neurological deficits or other physical disorders. The mechanism of this swallowing disorder is still not well understood. Based on various studies that have been conducted, the condition of psychogenic dysphagia has comorbidity with psychological disorders such as anxiety disorders, depression, and post-traumatic stress. In this case report, we will present a case of a 7-year-old male patient who had difficulty swallowing due to fear of vomiting with disturbed psychosocial conditions, and no organic disorders were found after the examination. The BDI examination showed a score of 18, which is within the border of clinical depression. So that the patient was diagnosed with psychogenic dysphagia which was included in the category of Avoidant/Restrictive Food Intake Disorder in DSM 5. Holistic and multidisciplinary treatment was needed in this case. It was also reported that the success of medical treatment to reduce the patient's vomiting symptoms from pediatrics and psychologist department, combined with supportive psychotherapy and family-based treatment increases the patient's recovery rate.
Amputation trauma due to burns is a conflict wound that is very emotionally disturbing, as is often shown on social media and on the small screen to illustrate war, but there are also unintentional events that occur in adolescents that cause burns due to electric shock. The purpose of this paper is to explain the psychiatric aspects and the role of Consultation-Liaison Psychiatry (CLP) in Traumatic Amputation Due to Electrical Burns in Adolescents so that it becomes a consideration in the selection of psychotherapy and therapy for patients. In this case report, an IPWS patient, male, 13 years old, was treated in the Burn Unit, 2nd floor, bed 2. The patient was consulted by a Plastic Surgery colleague at Sanglah Hospital Denpasar. Autoanamnesis data was obtained at the first examination, and the patient followed up during treatment with complaints of feeling sad due to the condition of the wound. The patient complains of sadness and guilt for not obeying his parents' advice not to fly kites in the field, sadness comes and goes, sometimes cries when he remembers and now he feels sad and sorry, he also wants to get well soon and be able to do activities.
Clinicians often overlook the presence of negative symptoms in treating schizophrenia. The burden borne by patients, families, and society is quite heavy. These symptoms not only have high costs, but also affect the functional prognosis in independence and socializing. There is a need for adequate therapy of negative symptoms of schizophrenia which can improve the patient’s quality of life. Negative symptoms are characterized by blunt affect, alogia, avolition, anhedonia, and asociality. Knowing the difference between the primary and secondary types of negative symptoms of schizophrenia can bring big impact on the therapy. The primary type of negative symptoms is an integral part of schizophrenia, while the secondary one is caused by external conditions of schizophrenia, such as depression. Management of negative symptoms of schizophrenia includes psychopharmaceuticals and non-psychopharmaceuticals. Atypical antipsychotics remain the drug of choice due to their affinity not only to D2 receptor, but also to serotonin, glutamate, histamine, α adrenergic, and muscarinic receptors. In addition, the higher dissociation rate of D2 receptors of atypical antipsychotics allow for minimal motor side effect. Cariprazine has been approved by The Food and Drug Associaton and The European Medicines Agency to treat primary and persistent negative symptoms due to its minimal side effect. Non-pharmacological therapies such as Cognitive Behavioral Therapy (CBT) and Motivation and Engagement Training (MOVE) can optimize the treatment efficacy. These therapies will enhance the cognitive improvement, adaptation, and social skill development of the patients.
Postpartum psychosis (PP) is the most severe peripartum mood disorder. PP incidence is rare and affecting about 0.1-0.2% of postpartum mothers. Many factors aggravate the mental condition of the mothers after the labor, including posterior reversible encephalopathy syndrome (PRES) that can cause the new mother suddenly become shocked. In this case report, a 21 years old married housewife was referred from Mangusada regional general hospital with complaints of sadness and restlessness (screaming). During history taking, the patient often screamed that she wants to see her child, she feels uncomfortable, and wants to die if it continued like this (unable to see and move at all). These complaints occurred at 8 days post-cesarean section. The patient couldn’t sleep, had any appetite, and restless for 2 days. The patient had much thought about her child’s condition and herself, but not clearly understood. Neurological examination found GCS E4V5Mx, visual acuity 1/300 ODS and weakness on all four extremities. The mental status examination found improper general appearance, looks sad, inadequate eye contact, mixed type insomnia, hypobulia, and raptus. The patient was diagnosed with unspecified severe mental and behavior disorder associated with puerperium (postpartum psychosis), given haloperidol tablet 0.75 mg every 12 hours orally and the non-pharmacological therapy was family psychoeducation and supportive psychotherapy. PRES can cause a mother stressful enough to manifest PP, it should be treated as early as possible to achieve complete recovery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.